IGF1 Receptors in Human Breast Tumors
Author Information
Author(s): H. Jammes, J.-P. Peyrat, E. Ban, M.-O. Vilain, F. Haour, J. Djian, J. Bonneterre
Primary Institution: Centre Oscar Lambret
Hypothesis
To assess the precise role of IGF1 in benign and malignant breast diseases.
Conclusion
The study found that IGF1 receptors are present in higher concentrations in breast cancer tissues compared to benign tumors and normal tissues.
Supporting Evidence
- IGF1 binding sites were detected in 18 human primary breast cancers, 12 benign breast tumors, and two normal breast tissues.
- The specific IGF1 binding was significantly higher in breast cancers compared to benign diseases.
- The median concentration of IGF1 binding in breast cancers was 30 fmoles mg-1 of proteins.
Takeaway
This study looked at how a growth factor called IGF1 is found in different types of breast tissues, showing it's more common in cancerous tissues than in benign ones.
Methodology
The study used histo-autoradiographic analysis to localize and quantify IGF1 binding sites in breast tissue samples.
Limitations
The study did not analyze all types of breast tumors and relied on a limited number of samples.
Participant Demographics
The study included patients undergoing surgery for primary breast cancer or benign breast tumors.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website